Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database

References

• Sedgh G, Finer LB, Bankole A, et al. Adolescent pregnancy, birth, and abortion rates across countries: levels and recent trends. J Adolesc Health. 2015;56:223–230.
   PubMed Web of Science ®Google Scholar
• Vilain A. The voluntary termination of pregnancy in 2013. Etud Rés. 2015;924:1–6.
   Google Scholar
• Finer LB, Zolna MR. Shifts in intended and unintended pregnancies in the United States, 2001-2009. Am J Public Health. 2014;104:S43–S48.
   PubMed Web of Science ®Google Scholar
• Henderson D. A third of women in UK who have an unintended pregnancy blame contraceptive failure. BMJ. 2009;339:b2975.
   PubMedGoogle Scholar
• Bajos N, Moreau C, Leridon H, et al. Why the number of abortions did not decrease in France since 30 years? Popul Soc (Paris). 2004;407: 1–4.
   Google Scholar
• Bajos N, Leridon H, Goulard H, et al. Contraception: from accessibility to efficiency. Hum Reprod. 2003;18:994–999.
   PubMed Web of Science ®Google Scholar
• Goulard H, Moreau C, Gilbert F, et al. Contraceptive failures and determinants of emergency contraception use. Contraception. 2006;74:208–213.
   PubMed Web of Science ®Google Scholar
• Moreau C, Trussell J, Desfreres J, et al. Patterns of contraceptive use before and after an abortion: results from a nationally representative survey of women undergoing an abortion in France. Contraception. 2010;82:337–344.
   PubMed Web of Science ®Google Scholar
• Leridon H, Oustry P, Bajos N. The increasing medicalisation of contraception in France. Popul Soc 2002;381:1–4.
   Google Scholar
• Gavin L, Moskosky S, Carter M, et al. Providing quality family planning services: Recommendations of CDC and the U.S. Office of Population Affairs. MMWR Recomm Rep. 2014;63:1–54.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). U.S. medical eligibility criteria for contraceptive use, 2010. MMWR Recomm Rep. 2010;59:1–86.
   Google Scholar
• Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2012;120:983–988.
   PubMedGoogle Scholar
• Trussell J. Update on and correction to the cost-effectiveness of contraceptives in the United States. Contraception. 2012;85:611.
   PubMed Web of Science ®Google Scholar
• Backman T, Huhtala S, Tuominen J, et al. Sixty thousand woman-years of experience on the levonorgestrel intrauterine system: an epidemiological survey in Finland. Eur J Contracept Reprod Health Care. 2001;6:23–26.
   Web of Science ®Google Scholar
• Diedrich JT, Zhao Q, Madden T, et al. Three-year continuation of reversible contraception. Am J Obstet Gynecol. 2015;213:e1–e8.
   PubMed Web of Science ®Google Scholar
• Faculty of Sexual and Reproductive Healthcare, Royal College of Obstetricians and Gynaecologists (2014). Progestogen-only implants. Available from: www.fsrh.org/documents/cec-ceu-guidance-implants-feb-2014/cec-ceu-guidance-implants-feb-2014.pdf.
   Google Scholar
• National Collaborating Centre for Women’s and Children’s Health. Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception. London: RCOG Press 2005.
   Google Scholar
• Agence Française de Sécurité Sanitaire et des Produits de Santé. Strategies for choosing female contraception methods. Guidelines for clinical practice. J Gynécol Obstét Biol Reprod. 2005; 34:406–409
   PubMedGoogle Scholar
• Secura GM, Madden T, McNicholas C, et al. Provision of no-cost, long-acting contraception and teenage pregnancy. N Engl J Med. 2014;371:1316–1323.
   PubMed Web of Science ®Google Scholar
• Berenson AB, Tan A, Hirth JM. Complications and continuation rates associated with 2 types of long-acting contraception. Am J Obstet Gynecol. 2015;212:e1–e8.
   PubMed Web of Science ®Google Scholar
• Cea Soriano L, Wallander MA, Andersson S, et al. The continuation rates of long-acting reversible contraceptives in UK general practice using data from The Health Improvement Network. Pharmacoepidemiol Drug Saf. 2015;24:52–58.
   PubMed Web of Science ®Google Scholar
• Caisse nationale de l’assurance maladie. Risque d’embolie pulmonaire, d’accident vasculaire cérébral ischémique et d’infarctus du myocarde chez les femmes sous contraceptif oral combiné en France: une étude de cohorte sur 4 millions de femmes de 15 à 49 ans à partir des données du SNIIRAM et du PMSI. Rapport final du 26 juin 2013. Available from: www.ameli.fr/fileadmin/user_upload/documents/rapport_cnamts_COC_26.06.2013.pdf.
   Google Scholar
• De Roquefeuil L, Studer A, Neumann A, et al. The Echantillon généraliste de bénéficiaires: representativeness, scope and limits. Prat Organ Soins. 2009;40:213–223.
   Google Scholar
• Moulis G, Lapeyre-Mestre M, Palmaro A, et al. French health insurance databases: what interest for medical research? Rev Med Interne. 2015;36:411–417.
   Google Scholar
• Palmaro A, Moulis G, Despas F, et al. Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies. Fundam Clin Pharmacol. 2016;30:616–624.
   PubMed Web of Science ®Google Scholar
• Latry P, Molimard M, Begaud B, et al. How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database. Eur J Clin Pharmacol. 2010;66:743–748.
   PubMed Web of Science ®Google Scholar
• Tuppin P, de Roquefeuil L, Weill A, et al. French national health insurance information system and the permanent beneficiaries sample. Rev Epidemiol Sante Publique. 2010;58:286–290.
   PubMed Web of Science ®Google Scholar
• Bajos N, Bohet A, Le Guen M, et al. Contraception in France: new context, new practices? Popul Soc. 2012;492:1–4.
   Google Scholar
• Moreau C, Bohet A, Hassoun D, et al. Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010. Fertil Steril. 2013;100:451–458.
   PubMed Web of Science ®Google Scholar
• Moreau C, Bouyer J, Bajos N, et al. Frequency of discontinuation of contraceptive use: results from a French population-based cohort. Hum Reprod. 2009;24:1387–1392.
   PubMed Web of Science ®Google Scholar
• Office for National Statistics. Contraception and sexual health 2008/2009. Opinions survey report 41. London: NHS Information Centre for Health and Social Care 2009.
   Google Scholar
• Kavanaugh ML, Jerman J, Hubacher D, et al. Characteristics of women in the United States who use long-acting reversible contraceptive methods. Obstet Gynecol. 2011;117:1349–1357.
   PubMed Web of Science ®Google Scholar
• Finer LB, Jerman J, Kavanaugh ML. Changes in use of long-acting contraceptive methods in the United States, 2007–2009. Fertil Steril. 2012;98:893–897.
   PubMed Web of Science ®Google Scholar
• Chiles DP, Roberts TA, Klein DA. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system. Am J Obstet Gynecol. 2016;215:e1–e9.
   PubMed Web of Science ®Google Scholar
• Harper CC, Rocca CH, Thompson KM, et al. Reductions in pregnancy rates in the USA with long-acting reversible contraception: a cluster randomised trial. Lancet. 2015;386:562–568.
   PubMed Web of Science ®Google Scholar
• Peipert JF, Madden T, Allsworth JE, et al. Preventing unintended pregnancies by providing no-cost contraception. Obstet Gynecol. 2012;120:1291–1297.
   PubMed Web of Science ®Google Scholar
• Secura GM, Allsworth JE, Madden T, et al. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol. 2010;203:e1–e7.
   PubMed Web of Science ®Google Scholar
• Speidel JJ, Harper CC, Shields WC. The potential of long-acting reversible contraception to decrease unintended pregnancy. Contraception. 2008;78:197–200.
   PubMed Web of Science ®Google Scholar
• Haute Autorité de Santé. Contraception chez l’homme et chez la femme. Avril 2013 updated in 2017:1–247. Available from: https://www.has-sante.fr/portail/plugins/ModuleXitiKLEE/types/FileDocument/doXiti.jsp?id=c_1528710.
   Google Scholar